aTyr Pharma ATYR Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's short- and long-term operating lease liabilities?
- aTyr Pharma (ATYR) reported short- and long-term operating lease liabilities of -$191K in Q1 2026.
- How has aTyr Pharma's short- and long-term operating lease liabilities changed year-over-year?
- aTyr Pharma's short- and long-term operating lease liabilities decreased by 17.9% year-over-year, from -$162K to -$191K.
- What is the long-term trend for aTyr Pharma's short- and long-term operating lease liabilities?
- Over 2 years (2021 to 2025), aTyr Pharma's short- and long-term operating lease liabilities has grown at a -9.1% compound annual growth rate (CAGR), from -$861K to -$711K.